Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 

Slides:



Advertisements
Similar presentations
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Advertisements

Volume 70, Issue 10, Pages (November 2006)
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Renal manifestations in Fabry disease and therapeutic options
Volume 82, Issue 1, Pages 7-8 (July 2012)
Viper venom for diabetic nephropathy
Volume 85, Issue 5, Pages (May 2014)
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
The Case ∣ Acute renal failure and anemia
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
John P. Middleton, Patrick H. Pun  Kidney International 
Renoprotective effects of vitamin D analogs
JAK/STAT signaling in renal diseases
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
The intrarenal renin-angiotensin system in hypertension
Better nephrology for mice—and man
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Glomerular filtration: the charge debate charges ahead
V.M. Campese, N. Mitra, D. Sandee  Kidney International 
Bioavailable vitamin D in chronic kidney disease
Volume 77, Issue 1, Pages 5-6 (January 2010)
Volume 64, Pages S39-S45 (October 2003)
Volume 84, Issue 1, Pages (July 2013)
Comorbidity and confounding in end-stage renal disease
Steven J. Rosansky, Richard J. Glassock  Kidney International 
Fernando Elijovich, Cheryl L. Laffer  Kidney International 
Volume 64, Pages S64-S70 (October 2003)
Timothy A. Sutton, Pierre C. Dagher  Kidney International 
U-shaped effect of eGFR and mortality
Osteopontin in diabetic nephropathy: signpost or road?
Volume 69, Issue 12, Pages (June 2006)
David M. Charytan, John P. Forman  Kidney International 
Disaster nephrology: crush injury and beyond
A physician's perseverance uncovers problems in a key nephrology study
Impact of gender on the renal response to angiotensin II
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
The future of renoprotection: Frustration and promises
Urinary biomarkers: the future looks promising
Alternate-day dialysis may be needed for hemodialysis patients
Calcium sensing in podocytes
Methods for guideline development
Angiotensin II production and distribution in the kidney: I
Angiotensin II production and distribution in the kidney – II
Nephrology Crossword: Glomerulonephritis
Insulin resistance and hypertension: new insights
New drug toxicities in the onco-nephrology world
Volume 73, Issue 9, Pages (May 2008)
Volume 57, Issue 5, Pages (May 2000)
Volume 82, Issue 9, Pages (November 2012)
Latest findings in phosphate homeostasis
Volume 73, Issue 5, Pages (March 2008)
Volume 83, Issue 5, Pages (May 2013)
Volume 68, Issue 5, Pages (November 2005)
Volume 80, Issue 10, Pages (November 2011)
Volume 81, Issue 12, Pages (June 2012)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Does an apple a day put hypertension in play?
Volume 75, Issue 7, Pages (April 2009)
Arya M. Sharma, Joachim Beige, Armin Distler  Kidney International 
Adiponectin: good, bad, or just plain ugly?
The international realities of live donor kidney transplantation
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 80, Issue 9, Pages (November 2011)
Volume 57, Issue 2, Pages (October 2000)
Proteinuria and hypertension with tyrosine kinase inhibitors
The Ebf1 knockout mouse and glomerular maturation
Presentation transcript:

Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney  Kidney International  Volume 85, Issue 5, Pages 1009-1011 (May 2014) DOI: 10.1038/ki.2013.440 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 A defect in glomerular permselectivity enhances renal angiotensin II generation. Loss of glomerular filtration barrier integrity permits significant amounts of angiotensinogen and renin into the tubular fluid. With angiotensin-converting enzyme present on the proximal tubule brush border, all the components required for robust angiotensin II generation are present in the tubular lumen. ACE, angiotensin-converting enzyme; AGT, angiotensinogen; Ang II, angiotensin II; AT1R, Ang II type 1 receptor. Kidney International 2014 85, 1009-1011DOI: (10.1038/ki.2013.440) Copyright © 2014 International Society of Nephrology Terms and Conditions